System-level and patient-level explanations for non-attendance at diabetic retinopathy screening in Sutton and Merton (London, UK): a qualitative analysis of a service evaluation by Strutton, R et al.
System-level and patient-level
explanations for non-attendance at
diabetic retinopathy screening in Sutton
and Merton (London, UK): a qualitative
analysis of a service evaluation
R Strutton,1 A Du Chemin,2,3 I M Stratton,4 A S Forster5,6
To cite: Strutton R, Du
Chemin A, Stratton IM, et al.
System-level and patient-level
explanations for non-
attendance at diabetic
retinopathy screening in
Sutton and Merton (London,
UK): a qualitative analysis of
a service evaluation. BMJ
Open 2016;6:e010952.
doi:10.1136/bmjopen-2015-
010952
▸ Prepublication history for
this paper is available online.
To view these files please
visit the journal online
(http://dx.doi.org/10.1136/
bmjopen-2015-010952).
Received 22 December 2015
Revised 21 March 2016
Accepted 29 April 2016
For numbered affiliations see
end of article.
Correspondence to
Dr A S Forster;
alice.forster@ucl.ac.uk
ABSTRACT
Objectives: Non-attendance at diabetic retinopathy
screening has financial implications for screening
programmes and potential clinical costs to patients. We
sought to identify explanations for why patients had
never attended a screening appointment (never
attendance) in one programme.
Design: Qualitative analysis of a service evaluation.
Setting: One South London (UK) diabetic eye
screening programme.
Participants and procedure: Patients who had been
registered with one screening programme for at least
18 months and who had never attended screening
within the programme were contacted by telephone to
ascertain why this was the case. Patients’ general
practices were also contacted for information about
why each patient may not have attended. Framework
analysis was used to interpret responses.
Results: Of the 296 patients, 38 were not eligible for
screening and of the 258 eligible patients, 159 were
not contactable (31 of these had phone numbers that
were not in use). We obtained reasons from patients/
general practices/clinical notes for non-attendance for
146 (57%) patients. A number of patient-level and
system-level factors were given to explain non-
attendance. Patient-level factors included having other
commitments, being anxious about screening, not
engaging with any diabetes care and being
misinformed about screening. System-level factors
included miscommunication about where the patient
lives, their clinical situation and practical problems that
could have been overcome had their existence been
shared between programmes.
Conclusions: This service evaluation provides unique
insight into the patient-level and system-level reasons
for never attendance at diabetic retinopathy screening.
Improved sharing of relevant information between
providers has the potential to facilitate increased uptake
of screening. Greater awareness of patient-level barriers
may help providers offer a more accessible service.
INTRODUCTION
Almost four million individuals in the UK
have been diagnosed with diabetes mellitus1
and an estimated 347 million worldwide.2
Diabetic retinopathy and maculopathy are
complications of diabetes mellitus that can
affect vision. Estimates suggest that around
5% of blindness globally is caused by diabetic
retinopathy and this is higher in Western
European countries (17%).3 Diabetic eye
disease can be detected early and treatments
are available to prevent blindness if given at
an early stage of the disease.4 5 Organised
diabetic eye screening programmes exist in a
number of Western European countries,
including in England. Individuals who have
diabetes mellitus, who are over the age of 12
are invited to attend screening every year
through a call and recall programme. There
is variation across the UK in how screening is
delivered: some programmes have dedicated
hospital clinics, whereas others are based
in GP surgeries or high-street optometrists.
Patients who have sight threatening diabetic
Strengths and limitations of this study
▪ Participants were never attenders at one diabetes
eye screening programme, who are a rarely
researched population, as by definition they do
not engage with diabetes eye screening.
▪ Significant effort was made to contact all never
attenders; there was no limit to the number of
contacts attempted until a patient was reached.
▪ Patients’ general practices (GPs) were also con-
tacted to ascertain why a patient may not have
attended diabetes eye screening, offering a tri-
angulation of findings.
▪ We ascertained reasons for non-attendance for
only 57% of patients; reasons for non-
attendance among patients who were not con-
tactable may differ from those who were.
▪ Responses were recorded as detailed notes by
the member of screening staff who contacted the
patients and providers; however, responses may
not have been recorded verbatim.
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retinopathy (STDR) detected (deﬁned as moderate or
severe non-proliferative retinopathy or proliferative retin-
opathy or referable maculopathy) are referred for treat-
ment or more frequent monitoring.
Non-attendance at diabetic eye screening is costly to
the UK National Health Service (NHS), with one pro-
gramme estimating that non-attendance cost >£78 000
($125 000 or €97 000) over 1 year.6 In quarter 3 of
2013/2014 around 83% of patients invited for diabetic
eye screening took up the offer.7 Many of the 17% who
were not screened will have attended in previous years,
but a proportion of patients have never attended for
screening despite being eligible. Patients who do not
attend for diabetic eye screening have risk factors that
make them more vulnerable to diabetic retinopathy,
including having poorer A1C and blood pressure
control and are more likely to have been diagnosed with
diabetes for longer.8 9 Patients who do not attend for
screening frequently are at increased risk of STDR and
risk increases with the duration that an individual is
unscreened.10
Patients who do not attend for screening are a vulner-
able population and some research has sought to con-
sider the reasons why patients may not be attending for
diabetic retinopathy screening. Barriers reported have
included patients believing that they do not have dia-
betic retinopathy, embarrassment about poor glycaemic
control, anxiety about treatment, conﬂicting priorities,
believing that other hospital eye appointments or
regular optometrist appointments test for diabetic retin-
opathy and lack of awareness of the importance of
screening.11–14 Service-level barriers have only been con-
sidered in research that has been conducted in the
context of screening performed at GP surgeries or high-
street optometrists and not community health clinic-
based screening.15 In addition, much of this work was
conducted outside of the UK, so may not be reﬂective
of the UK context, where screening is offered free-
at-the-point-of-receipt through an organised call and
recall system. Research that has considered service-level
barriers has suggested that we need a greater under-
standing of the communication between retinopathy
screening stakeholders (ie, general practice and screen-
ing programmes).15
We report the ﬁndings of a service evaluation of all
active patients who were registered with one diabetic eye
screening programme for at least 18 months and who
had never attended screening at one community health
clinic screening programme (n=296). The study sought
to explore the patient-level (ie, those determined to
some extent by the patient) and system-level (ie, those
determined by the healthcare provider) reasons for
never attendance at diabetic eye screening.
METHODS
The service evaluation was based in one South London
diabetic eye screening programme (there are 61 such
programmes in the UK). In this programme screening is
organised centrally and appointments offered in dedi-
cated community health clinics. In 2012/2013 this
screening programme had 18 334 registered patients on
their database, and an uptake rate of 84%. The screen-
ing programme identiﬁed all active patients, registered
on the screening database for at least 18 months, who
had never attended diabetic eye screening within the
programme as of 31 March 2012 (n=296). Patients and
general practice staff were contacted by a female
member of the screening programme staff (RS) to ascer-
tain why patients had not attended for screening.
General practice staff were GPs, nurses and administra-
tive staff. RS was qualiﬁed to make such enquiries as it
was part of her usual job, but this means that she was
also interested in increasing attendance. As patients
were never attendees at this service, RS did not have a
relationship with patients prior to the study. Detailed
notes were recorded for each contact made with patients
and providers. Existing clinical notes on primary care
and community databases were also searched systematic-
ally. A review of consent and eligibility coding on
primary care databases was undertaken and this informa-
tion was cross-referenced with patients’ status on the
screening database to indicate where further relevant
information may be held by primary care. Reasons given
to explain why patients wanted to opt out of the pro-
gramme during the period were recorded for those who
returned opt-out forms. Three standardised emails were
sent to non-responding practices and each practice
received two phone calls which were initiated in the
same way. The member of screening staff attempted to
contact eligible patients between 1 October 2012 and 31
March 2013, including on weekends (there was no limit
to the number of contacts attempted; mean number of
contacts=2.5 per patient). Patient phone conversations
were initiated in the same way, but conversations inevit-
ably differed beyond that. Patients’ age, gender and eth-
nicity were collected where available. The same number
of data sources was accessed for each patient; there was
no hierarchy (ie, if contact was made with a patient,
their provider was still contacted and clinical notes still
searched).
Framework analysis was used to qualitatively organise
the patients’ and providers’ responses and identify cat-
egories that arose from the data.16 This ﬂexible method
of coding allows easy retrieval of information within and
between cases. The process of charting is transparent
allowing others to judge the reliability of the interpret-
ation of the data. Analysis comprises ﬁve stages: familiar-
isation, the development of a thematic framework,
indexing, charting and mapping. Patients’ and provi-
ders’ responses were coded using the thematic frame-
work in Microsoft Excel. A second rater reviewed 10% of
cases. Agreement between raters was moderate (Cohen’s
κ=0.71, p<0.001). Disagreements were resolved by discus-
sion. Quotes are provided to give examples of the
content of the codes. The quotes are taken from the
2 Strutton R, et al. BMJ Open 2016;6:e010952. doi:10.1136/bmjopen-2015-010952
Open Access
group.bmj.com on May 19, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
detailed notes of telephone/email contact with the
patient or provider or as recorded in clinical notes.
These data were collected as part of a service evalu-
ation (CQUIN) and performed in line with the provi-
der’s Trust guidelines.
RESULTS
Descriptive characteristics of the sample
There were 296 active patients registered on the screen-
ing database for at least 18 months who had never
attended diabetic eye screening within the programme
as of 31 March 2012 (at this one screening programme).
Contact with patients and providers during the study
identiﬁed 38 patients who were ineligible for screening,
including patients who were not diabetic, who had
attended previously and so were not due to be screened,
who were under ophthalmology care, who were
deceased and who were being seen at another eye
screening programme. Of the remaining 258 patients,
practices provided reasons for non-attendance for 90
patients. During the period, 159 patients were not con-
tactable (31 of these had telephone numbers that were
not in use/had no contact number) and 21 patients did
not give a meaningful reason for their non-attendance.
We obtained reasons from patients, providers or clinical
notes for 146 (57%) patients.
The gender split was balanced in the sample (53%
men). The greatest proportion of patients was in the age
group 54–74 years (40%; table 1). Patients’ ethnicity and
main language spoken was available for 162 (62%) and
78 (30%) patients, respectively. Where known, most
patients were from a White ethnic background (36%),
followed by patients from an Asian or Asian British back-
ground (19%). Of patients whose ﬁrst language was
known, most spoke English (81%). There were 35
patients who were identiﬁed as having no general
practitioner (14%; table 1). During the study, 15 patients
opted out of the screening programme (6%) by return-
ing a signed opt-out form in line with national policy.
Qualitative analysis
A number of patient-level and system-level factors were
given to explain non-attendance.
Patient-level factors
Other commitments
For a number of patients, competing factors were priori-
tised more than screening, including having work and
childcare commitments, personal or family illness and
bereavements. Others were out of the area or country
for a period of time and so could not attend. Such
reasons were reported by patients and providers.
I [screening staff] called patient and his mother said that
he is very ill at the moment…She said that he vomits a
lot so it is difﬁcult to get to appointments. Male, 35 to
54 years.
Patient … said it’s difﬁcult to attend because her daugh-
ter has had a break down and she is looking after her
children. Female, 55 to 74 years.
Patient called to apologise for missing his appointment
this morning as he is … on business at present. He said
he was aware he has missed a few now and needs to be
seen. Male, 35 to 54 years.
Anxiety about screening
The most common anxiety expressed was that of patients
disliking the eye drops used during screening (some
anticipated disliking them, whereas others may have
received drops if screened by another programme previ-
ously). This was reported by patients and providers.
Other patients expressed a preference to have a family
member accompany them, and it was their family
member’s unavailability that had prevented them from
attending (in spite of transport being offered by the
screening programme).
Patient apologised for causing any problems and said she
had the drops once and remembers it was ok but has
since read that they can sting and she has built up a
phobia about it. Female, 35 to 54 years.
Disengagement with diabetes care in general
Some relatives of patients and general practice staff
reported that patients had disengaged with their dia-
betes care in general.
[Patient] is refusing to even discuss his condition, so all
you can do is keep sending invites. Male, 55 to 74 years.
[Father] told me [screening staff] that she [patient]
refuses to go to any appointments even though both he
and her mother encourage her. He said that the diabetes
nurse told them she is in denial about her diabetes and
Table 1 Patients’ demographic characteristics (n=258)
n Per cent
Ethnicity
White 94 36.4
Black or Black British 15 5.8
Asian or Asian British 49 19.0
Mixed 4 1.6
Unknown 96 37.2
Main language spoken
English 63 24.4
Other 15 5.8
Unknown 180 69.8
Age (group in years)
12–34 33 12.8
35–54 80 31.0
55–74 103 39.9
≥75 41 15.9
Missing 1 0.4
No general practitioner 35 13.6
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that she has been this way since she was diagnosed.
Female, 12 to 34.
Misinformed about screening
A number of patients and a few general practice staff
provided reasons for their/their patients’ non-
attendance that demonstrated them being misinformed.
These included: not understanding that diabetic retin-
opathy screening is not performed as part of a standard
optician eye test, not knowing where the screening clinic
is, patients believing that they are not diabetic (although
conﬁrmed by GP) and patients being seen in a glau-
coma clinic and perceiving this to be sufﬁcient diabetes
eye care.
Patient said … her opticians do all her eye checks.
Female, 35 to 54 years.
Forgetting
One patient reported that their non-attendance at
screening was due to them forgetting to attend.
System-level factors
There were also a number of system-level factors that
were related to screening non-attendance. Many of these
could have been overcome had there been better com-
munication between services.
Miscommunication about patients’ residence
Some patients were reported by general practice staff to
be known to be out of the area/country, some perman-
ently. A small number of patients were known by general
practice staff to have no ﬁxed abode.
Practical problems
There were also practical problems that were barriers to
screening attendance among patients, but could have
been overcome had the screening programme been
aware of them. These included patients being house-
bound (reported by providers) and having transport
problems (transport problems included general practice
staff not knowing how to book patient transport;
reported by patients and providers).
[Patient] called the GP to say that his transport has not
turned up. I [screening staff] called… transport and they
said that they went to an address but there was no answer
(this was his old address). I advised that this is not his
address…He apologised and said he will call the patient
and get him here today. Male, 55 to 74 years.
Invitation letter not received/not received in time
For some patients, issues with their post made it difﬁcult
for them to attend. It is important to note that appoint-
ment letters are sent out 3–4 weeks in advance of
appointments.
[Patient] said that normally when she receives our letters
it is the day before the appointment so there is not
enough notice. She believes there may be a problem with
her post. Female, 35 to 54 years.
[Patient] says he does not receive our letters because
someone where he lives throws them away. He asked for
them to be sent to his work. Male, 35 to 54 years.
Clinical notes not being shared
Eligibility and consent codes applied to patients’
primary care records were cross-referenced with
patients’ statuses on the screening database. This identi-
ﬁed one patient whom their GP had recorded ‘not indi-
cated for diabetic retinopathy screening’, one patient
who was coded as being unsuitable for digital retinal
photography, 31 patients whom their GP had recorded
as having ‘refused diabetic retinopathy screening’ and
40 patients who were ‘exempted from diabetes quality
indicators’ in the practice. All of these patients were
recorded as eligible for screening on the screening data-
base system.
DISCUSSION
This service evaluation sought to explore patient-level
and system-level explanations for never attendance at
diabetic eye screening at this programme. Patient-factors
identiﬁed during the service evaluation included having
other commitments, being anxious about screening,
patients not being engaged with any of their diabetes
care and being misinformed about screening.
System-level factors included miscommunication about
patients’ residences and practical problems that could
have been resolved if they were communicated between
service providers.
Many of the patient-level barriers to diabetic eye
screening have been reported previously,11–13 however,
the system-level factors rarely come out of the published
literature and our study provides new knowledge in this
area.14 15 Where they have been considered, communi-
cation issues between GPs and Diabetes Eye Screening
Programmes have previously been reported in the
context of GP surgery-based services.15 Uniquely, in our
service evaluation, a number of patients were found to
be either temporarily or permanently ineligible for
screening. Many of the telephone numbers available for
patients were no longer in use, suggesting that this
population is highly mobile. Better communication
between GP surgeries and screening programmes involv-
ing more streamlined methods of transferring relevant
information will help ensure that screening lists only
include eligible individuals. It may be useful for commis-
sioners and general practices to review the systems cur-
rently in place to communicate this information to the
screening programmes, to make sure that it is intuitive
and simple for practices to do. Screening providers are
currently penalised for the non-attendance of patients
who are actually ineligible for screening. Better commu-
nication could also facilitate patients who require
4 Strutton R, et al. BMJ Open 2016;6:e010952. doi:10.1136/bmjopen-2015-010952
Open Access
group.bmj.com on May 19, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
transport to attend screening. It would also be useful for
general practices to inform screening programmes if
they know that their patient will be out of the country
for a period of time. Previous research has also raised
the concern that patients being abroad for periods of
time means that they miss the annual screening cycle.15
Some patients were known to have no ﬁxed abode;
these patients are a vulnerable group and screening pro-
grammes and GPs need to ﬁnd ways to support their
attending screening. Some of the patient-level factors
inﬂuencing screening attendance will be more difﬁcult
for screening programmes to surmount, particularly per-
sonal or family illness and bereavement. Currently dia-
betes eye screening programmes continue to invite
patients regardless of non-attendance (unless an opt-out
form is returned) and such a strategy may be beneﬁcial
to patients with temporary personal issues, as the ﬁnd-
ings of this study suggest that they will attend when they
are able to. Patients’ work commitments being a barrier
to screening attendance could be overcome by increased
awareness of extended opening hours. Some of the non-
attendees were misinformed or anxious about screening.
Screening programmes may be able to improve their
invitation letter or information materials so that anxiety
is better managed. It might be useful to review existing
patient information with a group of patients to ensure
that directions to the screening clinics and accessibility
information are easily understood.
A number of patients were considered to be disen-
gaged with all of their diabetes care, and as such repre-
sent a vulnerable group of patients as it is known that
non-attenders are more likely to have poorer A1C and
blood pressure control and are more likely to have been
diagnosed with diabetes for longer.8 9 These ‘hard to
reach’ groups have been described previously.15
Disengaged and very resistant patients are a difﬁcult
group for screening programmes to engage, and it
might be easier or more appropriate for the GP or prac-
tice nurse to persist in encouraging these patients to par-
ticipate in their diabetes care, while recognising that it is
patients’ choice and responsibility to look after their
health.
There are some notable limitations to this service
evaluation. We were only able to ascertain reasons for
non-attendance for 57% of eligible patients. Non-
attenders are a notoriously difﬁcult population to
conduct research with and our ﬁndings provide insight
into the reasons for their non-attendance. However, the
reasons for non-attendance among patients who were
not contactable may differ from those who were.
Responses were recorded as detailed notes by the
member of screening staff who contacted the patients
and providers; however, there remains the possibility
that responses were not recorded verbatim. The reasons
that patients’ provided may have been subject to
responder bias, whereby they gave answers that they
thought the screening programme wanted to hear.
Similarly, clinical notes and general practice staff
perceptions’ may not accurately reﬂect patients’ reasons
for non-attendance. It would have been interesting to
explore associations between patients’ reasons for non-
attendance and their diabetes care or control; however,
the UK diabetes eye screening programmes do not rou-
tinely have access to clinical data. All patients spoken to
during the service evaluation could speak English
(although some had limited English). The information
provided to patients about the screening programme is
available in languages other than English, but this is not
made clear on the standard information. Previous
research has indicated that language barriers affect
attendance,15 but we were unable to explore this in our
study. While patients were considered to be non-
attenders at this one screening programme, it is possible
that they had attended screening at least 18 months pre-
viously at another screening programme. Our ﬁndings
may not be reﬂective of patients registered with other
screening programmes. Finally, while our results are
likely to be generalisable to other programmes in the
England that have similar populations, the system factors
may differ between programmes that employ different
screening models. Our results may also not be generalis-
able to programmes in other countries that employ both
different models of screening and have a different
screening population.
CONCLUSIONS
Improved sharing of relevant information between
healthcare services has the potential to facilitate
increased uptake of diabetic eye screening in patients
who have not previously attended screening. Increased
awareness of patient-level barriers may be used by
screening programmes to provide a more accessible
service.
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